ADVA
21.9.2021 09:02:50 CEST | Business Wire | Press release
ADVA (FSE: ADV) and SIA, Indra’s cybersecurity company, today announced that RedIRIS is deploying ADVA’s technology to create a robust, high-capacity research and education network (NREN). The new long-haul backbone infrastructure connects universities and research facilities across Spain, enabling educators and scientists to share huge data sets and harness bandwidth-intensive applications. Built on the ADVA FSP 3000 and monitored by the ADVA ALM fiber assurance solution, the network carries services at speeds up to 200Gbit/s. Featuring ADVA’s ROADM technology and QuadFlex™ line cards, the open solution has given RedIRIS an easy way to migrate from legacy technology to flexible, high-performance connectivity.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210921005058/en/
“Our new transport system empowers Spain’s scientists and academics to work together on national and international projects under optimum conditions. With flexible coherent wavelengths up to 200Gbit/s, it provides secure, highly reliable access to everything from video conferencing tools to high-performance remote computing facilities,” said Esther Robles, head of communications networks, RedIRIS. “ADVA’s open FSP 3000 technology enabled a smooth and painless transition from our existing transport infrastructure. With its modular design, it also provides massive scale, giving us the freedom to easily expand and evolve our network to meet future needs.”
Connecting more than 80 points of presence and over 500 institutions, RedIRIS’s new backbone network includes long-haul single-span submarine links to Spain’s Balearic Islands and the city of Melilla, as well as connections to the Canary Islands, the Canarian Institute of Astrophysics and its observatories. For flexibility and high spectral efficiency, the solution features ADVA’s flexgrid multi-degree ROADMs, enabling high-speed coherent and high-baud-rate transport. Through ADVA’s MicroMux™ technology, the new infrastructure also supports a seamless mix of 10Gbit/s and 100Gbit/s Ethernet client ports without any footprint increase. This optimizes space efficiency and ensures no stranded bandwidth. The network upgrade also involved the deployment of a solid and thorough migration plan by SIA, a leading Indra company in cybersecurity and ADVA’s Select partner.
“RedIRIS’s long-haul infrastructure is now one of Europe’s most advanced NRENs. It will enable researchers and teachers in Spain to leverage a new breed of data-intensive applications and collaborate in new ways using innovative video conferencing and augmented reality tools,” commented Hartmut Müller-Leitloff, SVP, sales, EMEA, ADVA. “Our open and scalable technology efficiently bridges the gap between the legacy needs and the future demand of RedIRIS’s users. Its unique client port flexibility supports a mix of 10Gbit/s and 100Gbit/s Ethernet services without the need for additional hardware. With our open optical layer, RedIRIS is also free to tackle rising demands in the future by expanding to higher baud rates and more complex modulation schemes.”
“For the design and deployment of a complex project like this, it has been key to walk hand in hand with our client RedIRIS, to perfectly understand its requirements and choose the right professionals with the knowledge and capacity to migrate to a new network that meets the organization’s present and future needs for a wide range of services. The project allows RedIRIS to carry encoded critical services that assure a greater level of cybersecurity with no latency,” stated Alejandro Díez, director, digital risk, SIA. “This deployment gives RedIRIS’s users in the research and scientific community an extremely powerful tool for high-quality collaboration and global connectivity. It also prepares Spain’s NREN for the key challenges of the future as it looks to connect more schools, universities, research centers, global libraries, smart cities and IoT. RedIRIS will operate as a critical infrastructure and will assure an immediate communication service with any other geographic point of the network, with robust processes and higher cybersecurity.”
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com .
About Indra
Indra is one of the leading global technology and consulting companies and the technological partner for core business operations of its customers world-wide. It is a world-leader in providing proprietary solutions in specific segments in Transport and Defense markets, and a leading firm in Digital Transformation and Information Technologies in Spain and Latin America through its affiliate Minsait. Its business model is based on a comprehensive range of proprietary products, with a high-value focus and with a high innovation component. In the 2020 financial year, Indra achieved revenue of €3.043 billion, near 48,000 employees, a local presence in 46 countries and business operations in over 140 countries. www.indracompany.com
About SIA
SIA is the Indra company leading the cybersecurity sector in Spain and Portugal, both in terms of turnover and expert talent, with more than 1,200 specialists. Its value proposition is based on the specific responses it offers organizations to meet the challenges and threats posed by the four forces of digitalization: regulatory pressure, connected infrastructures, the transformation of IT architectures and the growing digital interaction of people; responses articulated through a set of specific measures and plans to minimize risk and maximize the protection of their businesses. Being a member of the Indra Group, one of the leading global technology and consultancy companies with business operations in 140 countries, provides SIA with a profound knowledge of the industries as well as a solid worldwide presence. Further information at www.sia.es .
About RedIRIS
RedIRIS is the Spanish academic and research network that provides advanced communication services to the scientific community and national universities. It is funded by the Ministry of Science and Innovation and is included in the Ministry’s map of Special Scientific and Technological Facilities (ICTS). It is managed by the Public Corporate Entity Red.es, which reports to the Ministry of Economic Affairs and Digital Transformation. RedIRIS has over 500 affiliated institutions, mainly universities and public research centres, which join this community by signing an affiliation agreement. www.rediris.es
Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210921005058/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom